Innovation for Your Health

All news from Hamburg
and Schleswig-Holstein


Kiel researchers build the world’s smallest machines

Great excitement at Kiel University: As the DFG (German Research Foundation) announced today (Thursday, May 21), it will continue to support the research on molecules which function like machines with...


Breakthrough in basic research: Kiel researchers discover new means against cancerous tumours

Researchers at the Institute of Pharmacy at Kiel University have developed chemical compounds which have demonstrated strong effects on tumours. The so-called "aromatic heterocyclic compounds" are...


Facio partners with Evotec and initiates FSHD drug discovery programme

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Facio Therapies ("Facio") announced today that they have entered into an agreement aimed at the identification of compounds...


Scientists X-ray anti-inflammatory drug candidates

Using DESY's ultra bright X-ray source PETRA III, scientists have decoded the molecular and three-dimensional structure of two promising drug candidates from the new group of Spiegelmers for the first...


William R. Gruver agrees to lead INDIVUMED business advisory team

Past General Partner and Chief Administrative Officer of the Equities Division of Goldman, Sachs & Co. and current member of the Board of Directors of the Pennsylvania-based Geisinger Health System...


Vaccine reliably activates the immune system response against Ebola

The initial results of a clinical Phase I trial of a potential vaccine against the dreaded Ebola virus are now available at the Hamburg-Eppendorf University Medical Center (UKE). As this trial was...


“FBÖ TransTechTrans” pilot phase ended – still vouchers to apply for

The pilot phase of the Swedish-Danish-German "FBÖ TransTechTrans” project has ended but Danish companies and research institutions within life sciences still have an opportunity to apply for a voucher...


Attack from all sides

Tuberculosis – a disease that knows no boundaries, kills millions of people per year worldwide and is developing resistance to current drug therapies at an alarming rate. In order to develop urgently...


The Netherlands in North Germany

The life science sector also showcased its strengths in front of the Dutch business delegation, which accompanied the royal couple Willem-Alexander and Máxima on its tour of North Germany as part of a...


Evotec and Sanofi sign definitive agreement for major multi-component strategic alliance

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been...

© Copyright Life Science Nord e.V.

All rights reserved. Especially reprint, incorporation in online services, internet and amplification using data vehicles like CD-Rom, DVD-ROM etc. even in extracts require written permission by Life Science Nord e.V. Life Science NOrd e.V. is not responsible for content of external links and and foreign contents.

In case you would like to use our newsletter via email as a free-of-charge and effective PR tool, please send us your company news that we eill publish in the following issue. Profit from this communication platform, make new contacts and take care of existing ones.


Simone Hauck
PR & Communications Manager

P +49.40.471 96-423


  • Desitin

Content loading failure